Pharmaceutical Co. Ltd. Jiangsu Zobon

Pharmaceutical Co., Ltd. Jiangsu Zobon are large state-owned enterprises under the Red Sun Group Corporation, a wholly owned subsidiary. The company occupies 200,000 square meters, total investment of 200 million yuan, is the focus of development and production of ephedrine products, as well as cardiovascular and cerebrovascular medicine, anti-infectives, respiratory medicine, endocrinology and metabolic vascular drugs, anti-infectives,